Why Amdocs Stock Is Back on Investors’ Radar
Amdocs (DOX) is drawing fresh investor attention after its stock declined about 21% year to date and about 30% over the past year, even as the company reports revenue and net income growth.
At the same time, Amdocs has been winning new large-scale contracts tied to cloud migration, generative AI, and data services, reflecting telecom and media clients’ ongoing digital transformation efforts.
See our latest analysis for Amdocs.
With the share price at US$60.84 and the year to date share price return down 24.1%, recent weakness continues a longer period where the 1 year total shareholder return declined 31.25% and the 3 year total shareholder return declined 30.07%, even as Amdocs secures more cloud and generative AI contracts.
If you are comparing Amdocs with other opportunities tied to digital infrastructure and automation, this is a good moment to scan the market using our screener for 48 AI infrastructure stocks
With the stock down sharply over 1 and 3 years while revenue and net income growth remain positive, investors are asking a simple question: is Amdocs now trading below its underlying potential, or is the market already factoring in future growth?
Most Popular Narrative: 14.1% Undervalued
Compared with the last close at $60.84, the most widely followed narrative points to a fair value of $70.84, framing Amdocs as undervalued on that view.
Even as acquisitions such as MATRIXX and Profinit expand Amdocs' product and geographic reach, the integration of these software businesses and alignment with Amdocs' model could temper near term contribution to earnings and keep operating margins tightly managed rather than sharply higher.
The fair value story rests on a specific path for revenue, profits and margins, plus a particular earnings multiple several years out. Curious which assumptions really carry the weight here? The narrative spells out how these moving parts fit together and what has to go right financially for $70.84 to make sense.
Result: Fair Value of $70.84 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, there are still clear swing factors, including faster adoption of Amdocs' generative AI platforms as well as a broader role in large cloud transformation programs.
Find out about the key risks to this Amdocs narrative.
Next Steps
Given the mix of caution and optimism in this narrative, it makes sense to look at the numbers yourself, move quickly, and stress test your own view against the 5 key rewards.
Looking for more investment ideas?
If you stop with just one stock, you risk missing opportunities that might fit your goals even better, so broaden your watchlist with a few targeted screens.
- Target potential mispricings by reviewing 47 high quality undervalued stocks that combine attractive prices with solid underlying businesses.
- Prioritise resilience first by scanning 65 resilient stocks with low risk scores that score well on stability and downside protection.
- Get ahead of the crowd by checking a screener containing 22 high quality undiscovered gems before they hit the mainstream radar.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com